Clinical Trial Update: Nebulized Ketamine for the Treatment of Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating nebulized ketamine for major depressive disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Theresa Jacob, PhD, MPH | Conditions: Severe Depression, Moderate Depression | Phase 3 | Status: RECRUITING